We spoke to new Sterling Energy CEO Tony Hawkins about the latest changes happening at the company. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,050.00
Bid: 8,188.00
Ask: 6,052.00
Change: -70.00 (-0.98%)
Spread: -2,136.00 (-26.09%)
Open: 7,030.00
High: 7,116.00
Low: 7,001.00
Yest. Close: 7,120.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Hillary Clinton Outlines Plans To Stop Drug Industry "Price Gouging"

23 Sep 15 08:32

LONDON MARKET CLOSE: Commodities And Pharma Push FTSE 100 Below 6,000

22 Sep 15 16:11

LONDON MARKET MIDDAY: Miners, Drug Makers And VW Drive FTSE 100 Lower

22 Sep 15 11:17

AstraZeneca taps crowd sourcing to find cancer drug cocktails

LONDON, Sept 22 (Reuters) - Drugmaker AstraZeneca is harnessing the wisdom of crowds to help mix tomorrow's cancer drug cocktails. The company said on Tuesday its decision to release preclinical data from more than 50 of its medicines was unprecedented in scale and would help accelerate the

22 Sep 15 07:44

LONDON MARKET OPEN: Drug Stocks Hit By Clinton Price-Gouging Tweet

22 Sep 15 07:38

LONDON BRIEFING: Miners And Drug Stocks Hit By Downgrades And A Tweet

22 Sep 15 07:23

Dunedin Income Growth Underperforms FTSE All Share In Half Year

21 Sep 15 09:55

Roche shows its intent with Switzerland's tallest skyscraper

By John Miller BASEL, Sept 18 (Reuters) - Visible from neighbouring France and Germany, a new 41-storey skyscraper that drugs company Roche opened near the river Rhine on Friday reaches 178 meters into the sky, easily the tallest building in Switzerland. The 550-million Swiss franc (

18 Sep 15 14:32

UPDATE 2-Lilly diabetes drug slashes deaths in patients with heart risk

(Adds analyst estimates on Jardiance sales and Lilly earnings, details on study, medical comment; updates share price) By Ransdell Pierson Sept 17 (Reuters) - Eli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack an

17 Sep 15 21:43

BUZZ-Lilly shares add to gains after diabetes drug finding

(Updates price, adds stock symbol) ** Shares of Eli Lilly and Co up 6 pct at $89.74, giving the biggest boost to the S&P 500, following positive drug news ** Its new Jardiance pill slashed deaths by 32 pct in a study of 7,000 patients with type 2 diabetes at risk of heart attack and s

17 Sep 15 17:12

Synairgen Swings To Loss As AstraZeneca Revenue Bump Doesn't Repeat

16 Sep 15 09:50

Broker tips: Henderson Group, AstraZeneca, IAG

(ShareCast News) - Exane BNP Paribas took a look at UK asset managers, noting that their shares have sold off sharply, making for an enticing entry point. "Equity market volatility is a risk to inflows, but historically the impact has been temporary and flows into other asset classes do not suffer a

14 Sep 15 16:39

LONDON MARKET CLOSE: UK Stocks Down As Analysts Differ On Fed Decision

14 Sep 15 16:16

LONDON MARKET MIDDAY: NY Seen Up As Fed Decision Week Gets Underway

14 Sep 15 11:12

Deutsche Bank ups AstraZeneca to 'buy'; sees return to strong growth

(ShareCast News) - Deutsche Bank upgraded AstraZeneca to 'buy' from 'hold' and raised its price target to 5,700p from 4,850p. The bank said it's increasingly confident in AstraZeneca's ability to deliver a return to strong growth from a base in 2017. "We have increased our outer year sales and earn

14 Sep 15 10:41

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.